Hemant Surgical Industries Ltd
BSE: 543916
₹468.25
₹6.80
(1.47%)
As on 11-Sep-2026IST
Market cap
₹681 Cr
Revenue (TTM)
₹107 Cr
P/E Ratio
37.4
P/B Ratio
4.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹8 Cr
-
ROE
12.7 %
-
ROCE
13.6 %
-
Industry P/E
48.49
-
EV/EBITDA
24.1
-
Debt to Equity
0.5
-
Book Value
₹60.5
-
EPS
₹7.7
-
Face value
10
-
Shares outstanding
14,537,600
10 Years Aggregate
CFO
₹22.78 Cr
EBITDA
₹51.99 Cr
Net Profit
₹35.59 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hemant Surgical
| 60.9 | 31.9 | 23.4 | 43.3 | 24.4 | -- | -- |
|
BSE Healthcare
| 18.0 | 0.1 | 9.1 | 14.7 | 21.9 | 14.1 | 11.9 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Hemant Surgical
| 130.9 | -25.2 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hemant Surgical
|
468.3 | 680.7 | 106.6 | 8.0 | -- | 12.7 | 37.4 | 4.7 |
| 1,129.6 | 2,151.2 | 77.0 | 16.4 | -- | 43.4 | 64.3 | 19.9 | |
| 2,922.3 | 48,214.8 | 6,725.3 | 1,128.8 | 19.6 | 11.5 | 42.7 | 4.5 | |
| 202.8 | 1,111.3 | 287.0 | 28.7 | 10.2 | 9.1 | 36 | 4.4 | |
| 660.2 | 7,933.9 | 7,229.4 | 210.4 | 4.4 | 11 | 37.7 | 4.0 | |
| 1,738.5 | 17,610.0 | 1,997.4 | 307.0 | 16.7 | 10.6 | 55.9 | 5.5 | |
| 407.0 | 488.5 | 75.1 | 21.7 | 32.1 | 18.1 | 22.5 | 3.7 | |
| 726.2 | 1,694.1 | 341.7 | 55.7 | -- | 25.6 | 30.4 | 3.5 | |
| 311.2 | 1,659.0 | 441.4 | 11.1 | 3.5 | 1.9 | 149.5 | 2.6 | |
| 540.2 | 591.1 | 19.3 | 17.3 | 4.8 | -2.1 | -- | 0.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Hemant Surgical
Manufacture of laboratory apparatus (laboratory ultrasonic cleaning machinery, laboratory sterilizers, laboratory type distilling apparatus, laboratory centrifuges etc.)
-
Incorporated
1989
-
Chairman
Hanskumar Shamji Shah
-
Managing Director
Hanskumar Shamji Shah
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Hemant Surgical Industries Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Hemant Surgical
What is the current share price of Hemant Surgical Industries Ltd Today?
The share price of Hemant Surgical Industries Ltd is ₹468.25 (BSE) as of 11-Sep-2026 IST. Hemant Surgical Industries Ltd has given a return of 24.39% in the last 3 years.
What is the current PB & PE ratio of Hemant Surgical Industries Ltd?
The P/E ratio of Hemant Surgical Industries Ltd is 37.42 times as on 11-Sep-2026, a 23 discount to its peers’ median range of 48.49 times.
The P/B ratio of Hemant Surgical Industries Ltd is 4.73 times as on 11-Sep-2026, a 28 premium to its peers’ median range of 3.70 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
12.94 |
1.65 |
2024 |
14.18 |
2.53 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Hemant Surgical Industries Ltd?
The 52-week high and low of Hemant Surgical Industries Ltd are Rs 497.00 and Rs 215.00 as of 14-Sep-2026.
What is the market cap of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a market capitalisation of ₹ 681 Cr as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Hemant Surgical Industries Ltd?
Before investing in Hemant Surgical Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.